Stay updated on Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new page revision entry v3.5.4 has been added to the revision history, and the previous revision v3.5.3 has been removed from the list.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page header/footer version has been updated from v3.5.2 to v3.5.3, reflecting a software/interface release rather than an update to the trial information.SummaryDifference0.0%

- Check50 days agoChange DetectedUpdated collaborator listing from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd., and updated the revision to v3.5.2 (replacing v3.5.0).SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This reflects an incremental system update and does not modify study content or user-facing features.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check114 days agoChange DetectedAdded Revision: v3.4.2 and removed the earlier Revision: v3.4.1 notice about government funding and operating status.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.